Molecular mechanisms of airway hyperresponsiveness in a murine model of steroid-resistant airway inflammation

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 963-977

  Manni, Michelle L ^a   Mandalapu, Sivanarayana ^a   McHugh, Kevin J ^a   Merle Elloso, M ^b   Dudas, Paul L ^b   Alcorn, John F ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 17; STAT6 PROTEIN; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHILIA; FEMALE; LUNG COMPLIANCE; LYMPHOCYTE TRANSFER; MOLECULAR PATHOLOGY; MOUSE; MUCUS SECRETION; MURINE MODEL; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; TH17 CELL; TH2 CELL; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG RESISTANCE; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; METAPLASIA; MUCUS; PATHOLOGY; POLYMERASE CHAIN REACTION; SCID MOUSE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; IMMUNOBLOTTING; INTERLEUKIN-13; INTERLEUKIN-17; METAPLASIA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; MUCUS; POLYMERASE CHAIN REACTION; RESPIRATORY HYPERSENSITIVITY; TH17 CELLS; TH2 CELLS; TRANSCRIPTOME;

EID: 84957717353     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501531     Document Type: Article

References (55)

1. Wenzel, S. 2012. Severe asthma: from characteristics to phenotypes to endo-types. Clin. Exp. Allergy 42: 650-658.
2. Xie, M., and S. E. Wenzel. 2013. A global perspective in asthma: from pheno-type to endotype. Chin. Med. J. (Engl.) 126: 166-174.
3. Manni, M. L., J. B. Trudeau, E. V. Scheller, S. Mandalapu, M. M. Elloso, J. K. Kolls, S. E. Wenzel, and J. F. Alcorn. 2014. The complex relationship between inflammation and lung function in severe asthma. Mucosal Immunol. 7: 1186-1198.
4. Hellings, P. W., A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens. 2003. Interleukin-17 orchestrates the gran-ulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28: 42-50.
5. Aujla, S. J., and J. F. Alcorn. 2011. T(H)17 cells in asthma and inflammation. Biochim. Biophys. Acta 1810: 1066-1079.
6. Hashimoto, T., K. Akiyama, N. Kobayashi, and A. Mori. 2005. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137(Suppl. 1): 51-54.
7. Berry, M. A., D. Parker, N. Neale, L. Woodman, A. Morgan, P. Monk, P. Bradding, A. J. Wardlaw, I. D. Pavord, and C. E. Brightling. 2004. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 114: 1106-1109.
8. Agache, I., C. Ciobanu, C. Agache, and M. Anghel. 2010. Increased serum IL-17 is an independent risk factor for severe asthma. Respir. Med. 104: 1131-1137.
9. Barczyk, A., W. Pierzchala, and E. Sozan-ska. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97: 726-733.
10. Saha, S. K., M. A. Berry, D. Parker, S. Siddiqui, A. Morgan, R. May, P. Monk, P. Bradding, A. J. Wardlaw, I. D. Pavord, and C. E. Brightling. 2008. Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J. Allergy Clin. Immunol. 121: 685-691.
11. Truyen, E., L. Coteur, E. Dilissen, L. Overbergh, L. J. Dupont, J. L. Ceuppens, and D. M. Bullens. 2006. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 61: 202-208.
12. Chen, J., Y. Deng, J. Zhao, Z. Luo, W. Peng, J. Yang, L. Ren, L. Wang, Z. Fu, X. Yang, and E. Liu. 2010. The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bron-chiolitis. J. Clin. Immunol. 30: 539-545.
13. Wang, M., Y. Zhang, D. Han, and L. Zhang. 2012. Association between polymorphisms in cytokine genes IL-17A and IL-17F and development of allergic rhinitis and comorbid asthma in Chinese subjects. Hum. Immunol. 73: 647-653.
14. Zhang, H., Q. Zhang, L. Wang, H. Chen, Y. Li, T. Cui, W. Huang, L. Zhang, F. Yan, L. Wang, et al. 2007. Association of IL4R gene polymorphisms with asthma in Chinese populations. Hum. Mutat. 28: 1046.
15. Vladich, F. D., S. M. Brazille, D. Stern, M. L. Peck, R. Ghittoni, and D. Vercelli. 2005. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J. Clin. Invest. 115: 747-754.
16. McKinley, L., J. F. Alcorn, A. Peterson, R. B. Dupont, S. Kapadia, A. Logar, A. Henry, C. G. Irvin, J. D. Piganelli, A. Ray, and J. K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181: 4089-4097.
17. Alcorn, J. F., L. M. Rinaldi, E. F. Jaffe, M. van Loon, J. H. Bates, Y. M. Janssen-Heininger, and C. G. Irvin. 2007. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am. J. Respir. Crit. Care Med. 176: 974-982.
18. Hantos, Z., B. Daróczy, B. Suki, S. Nagy, and J. J. Fredberg. 1992. Input impedance and peripheral inhomogeneity of dog lungs. J. Appl. Physiol. 72: 168-178.
19. Bates, J. H., and C. G. Irvin. 2003. Measuring lung function in mice: the phe-notyping uncertainty principle. J. Appl. Physiol. 94: 1297-1306.
20. Evans, C. M., K. Kim, M. J. Tuvim, and B. F. Dickey. 2009. Mucus hyperse-cretion in asthma: causes and effects. Curr. Opin. Pulm. Med. 15: 4-11.
21. Long, A. J., J. P. Sypek, R. Askew, S. C. Fish, L. E. Mason, C. M. Williams, and S. J. Goldman. 2006. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am. J. Respir. Cell Mol. Biol. 35: 357-365.
22. Huang, F., S. Wachi, P. Thai, A. Loukoianov, K. H. Tan, R. M. Forteza, and R. Wu. 2008. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J. Allergy Clin. Immunol. 121: 1415-1421, 1421.e1-3.
23. Cheng, D., Z. Xue, L. Yi, H. Shi, K. Zhang, X. Huo, L. R. Bonser, J. Zhao, Y. Xu, D. J. Erle, and G. Zhen. 2014. Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma. Am. J. Respir. Crit. Care Med. 190: 639-648.
24. Bouffi, C., M. Rochman, C. B. Zust, E. M. Stucke, A. Kartashov, P. C. Fulkerson, A. Barski, and M. E. Rothenberg. 2013. IL-33 markedly activates murine eo-sinophils by an NF-kB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J. Immunol. 191: 4317-4325.
25. Newcomb, D. C., M. G. Boswell, M. M. Huckabee, K. Goleniewska, D. E. Dulek, S. Reiss, N. W. Lukacs, J. K. Kolls, and R. S. Peebles, Jr. 2012. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J. Immunol. 188: 1027-1035.
26. Hoshino, A., T. Tsuji, J. Matsuzaki, T. Jinushi, S. Ashino, T. Teramura, K. Chamoto, Y. Tanaka, Y. Asakura, T. Sakurai, et al. 2004. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int. Immunol. 16: 1497-1505.
27. Mowen, K. A., and L. H. Glimcher. 2004. Signaling pathways in Th2 development. Immunol. Rev. 202: 203-222.
28. Brightling, C., M. Berry, and Y. Amrani. 2008. Targeting TNF - Alpha: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 121: 5-10, quiz 11-12.
29. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
30. Souwer, Y., K. Szegedi, M. L. Kapsenberg, and E. C. de Jong. 2010. IL-17 and IL-22 in atopic allergic disease. Curr. Opin. Immunol. 22: 821-826.
31. Tomkinson, A., C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M. C. Shanafelt, R. Gundel, and E. W. Gelfand. 2001. A murine IL-4 receptor antagonist that inhibits IL-4 - And IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166: 5792-5800.
32. Wenzel, S., D. Wilbraham, R. Fuller, E. B. Getz, and M. Longphre. 2007. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370: 1422-1431.
33. Wenzel, S., L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, L. Wang, S. Kirkesseli, R. Rocklin, B. Bock, et al. 2013. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368: 2455-2466.
34. Wenzel, S. E., L. Wang, and G. Pirozzi. 2013. Dupilumab in persistent asthma. N. Engl. J. Med. 369: 1276.
35. De Boever, E. H., C. Ashman, A. P. Cahn, N. W. Locantore, P. Overend, I. J. Pouliquen, A. P. Serone, T. J. Wright, M. M. Jenkins, I. S. Panesar, et al. 2014. Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial. J. Allergy Clin. Immunol. 133: 989-996.
36. Corren, J., R. F. Lemanske, N. A. Hanania, P. E. Korenblat, M. V. Parsey, J. R. Arron, J. M. Harris, H. Scheerens, L. C. Wu, Z. Su, et al. 2011. Leb-rikizumab treatment in adults with asthma. N. Engl. J. Med. 365: 1088-1098.
37. Busse, W. W., S. Holgate, E. Kerwin, Y. Chon, J. Feng, J. Lin, and S. L. Lin. 2013. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am. J. Respir. Crit. Care Med. 188: 1294-1302.
38. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
39. Zhu, J., L. Guo, C. J. Watson, J. Hu-Li, and W. E. Paul. 2001. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166: 7276-7281.
40. Yang, M., S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2001. Interleukin-13 mediates airways hy-perreactivity through the IL-4 receptor - Alpha chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 25: 522-530.
41. Munitz, A., E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg. 2008. Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 7240-7245.
42. Akimoto, T., F. Numata, M. Tamura, Y. Takata, N. Higashida, T. Takashi, K. Takeda, and S. Akira. 1998. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 187: 1537-1542.
43. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187: 939-948.
44. Newcomb, D. C., M. G. Boswell, T. P. Sherrill, V. V. Polosukhin, K. L. Boyd, K. Goleniewska, S. L. Brody, J. K. Kolls, K. B. Adler, and R. S. Peebles, Jr. 2013. IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia. Am. J. Respir. Cell Mol. Biol. 48: 711-716.
45. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8: 885-889.
46. Kuperman, D. A., X. Huang, L. Nguyenvu, C. Hölscher, F. Brombacher, and D. J. Erle. 2005. IL-4 receptor signaling in Clara cells is required for allergen-induced mucus production. J. Immunol. 175: 3746-3752.
47. Roy, M. G., A. Livraghi-Butrico, A. A. Fletcher, M. M. McElwee, S. E. Evans, R. M. Boerner, S. N. Alexander, L. K. Bellinghausen, A. S. Song, Y. M. Petrova, et al. 2014. Muc5b is required for airway defence. Nature 505: 412-416.
48. Young, H. W., O. W. Williams, D. Chandra, L. K. Bellinghausen, G. Pérez, A. Suárez, M. J. Tuvim, M. G. Roy, S. N. Alexander, S. J. Moghaddam, et al. 2007. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 59 elements. Am. J. Respir. Cell Mol. Biol. 37: 273-290.
49. Chapoval, S. P., P. Dasgupta, E. P. Smith, L. J. DeTolla, M. M. Lipsky, A. E. Kelly-Welch, and A. D. Keegan. 2011. STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease. J. Immunol. 186: 2571-2583.
50. Iwata, A., S. Kawashima, M. Kobayashi, A. Okubo, H. Kawashima, A. Suto, K. Hirose, T. Nakayama, and H. Nakajima. 2014. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int. Immunol. 26: 103-114.
51. Dorsey, N. J., S. P. Chapoval, E. P. Smith, J. Skupsky, D. W. Scott, and A. D. Keegan. 2013. STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. J. Immunol. 191: 1517-1528.
52. Doherty, T. A., N. Khorram, S. Lund, A. K. Mehta, M. Croft, and D. H. Broide. 2013. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J. Allergy Clin. Immunol. 132: 205-213.
53. Bando, J. K., J. C. Nussbaum, H. E. Liang, and R. M. Locksley. 2013. Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung. J. Leukoc. Biol. 94: 877-884.
54. Perkins, C., N. Yanase, G. Smulian, L. Gildea, T. Orekov, C. Potter, F. Brombacher, B. Aronow, M. Wills-Karp, and F. D. Finkelman. 2011. Selective stimulation of IL-4 receptor on smooth muscle induces airway hyper-responsiveness in mice. J. Exp. Med. 208: 853-867.
55. Choy, D. F., K. M. Hart, L. A. Borthwick, A. Shikotra, D. R. Nagarkar, S. Siddiqui, G. Jia, C. M. Ohri, E. Doran, K. M. Vannella, et al. 2015. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci. Transl. Med. 7: 301ra129.